Biohaven Pharma (BHVN) Q2 NURTEC ODT Sales Rise to $93M

Go back to Biohaven Pharma (BHVN) Q2 NURTEC ODT Sales Rise to $93M
(NYSE: BHVN) Delayed: 14.22 --0 (-0%)
Previous Close $14.22    52 Week High
Open $14.22    52 Week Low
Day High $14.22    P/E N/A 
Day Low $14.22    EPS
Volume 32,701